TOLLIP and idiopathic pulmonary fibrosis: This has fueled the design of the Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) trial, which aims to assess N-acetylcysteine response based on TOLLIP gene variants in IPF.